| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
American Journal of Pathology, Vol 137, 833-843, Copyright © 1990 by American Society for Investigative Pathology
REGULAR ARTICLES |
Y Ke, BI Gerwin, SE Ruskie, AM Pfeifer, CC Harris and JF Lechner
Division of Cancer Etiology, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892.
Sparse (75 to 2000 cells/cm2) density cultures of normal human bronchial epithelial cells uniformly undergo terminal squamous differentiation when incubated in medium containing serum (fetal bovine serum [FBS]) or transforming growth factor beta-1 (TGF-beta 1). It was found that the cell density of the culture affects the probability that a cell will respond to these differentiation-inducing agents. Thus whereas irreversible inhibition of DNA synthesis occurs in sparse cell- density cultures within 24 hours after exposure, only a transient (less than 36 hours) depression in DNA synthesis was seen in high (more than 10,000 cells/cm2) density cultures. In addition, although phase microscopic image analysis revealed that virtually all of the cells displayed a squamous morphology within 1 hour after exposure to FBS or TGF-beta 1, observations made 48 to 72 hours later showed the presence of clusters of small prolate spheroid-shaped cells surrounded by many involucrin-positive squamous-appearing cells. Only the small cells were capable of DNA synthesis and cell division as determined by autoradiography and time-lapse photomicrographic images. These replicating cells immediately undergo squamous differentiation if they are subcultured and reinoculated at low cell density and incubated in medium supplemented with FBS or TGF-beta 1. Therefore the probability that a human bronchial epithelial cell will be refractive to FBS- or TGF-beta 1 induced terminal squamous differentiation is solely a function of the cell density of the culture.
This article has been cited by other articles:
![]() |
M. M. Myerburg, J. D. Latoche, E. E. McKenna, L. P. Stabile, J. S. Siegfried, C. A. Feghali-Bostwick, and J. M. Pilewski Hepatocyte growth factor and other fibroblast secretions modulate the phenotype of human bronchial epithelial cells Am J Physiol Lung Cell Mol Physiol, June 1, 2007; 292(6): L1352 - L1360. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Coste, J.-P. Lefaucheur, Q.-P. Wang, E. Lesprit, F. Poron, R. Peynegre, and E. Escudier Expression of the Transforming Growth Factor {beta} Isoforms in Inflammatory Cells of Nasal Polyps Arch Otolaryngol Head Neck Surg, December 1, 1998; 124(12): 1361 - 1366. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. You and S. B. Jakowlew Identification of Early Growth Response Gene-1 (Egr-1) as a Phorbol Myristate Acetate-induced Gene in Lung Cancer Cells by Differential mRNA Display Am. J. Respir. Cell Mol. Biol., November 1, 1997; 17(5): 617 - 624. [Abstract] [Full Text] |
||||
![]() |
S Boland, E Boisvieux-Ulrich, O Houcine, A Baeza-Squiban, M Pouchelet, D Schoevaert, and F Marano TGF beta 1 promotes actin cytoskeleton reorganization and migratory phenotype in epithelial tracheal cells in primary culture J. Cell Sci., January 9, 1996; 109(9): 2207 - 2219. [Abstract] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |